Covid-19
Convalescent
Plasma

Supporting high quality evaluation of
CCP throughout Europe

Learn more >

Project
description

SUPPORT-E - SUPPORTing high quality
evaluation of Covid-19 convalescent plasma
throughout Europe -
is a research project
supported by the European Commission which
brings together major European Blood
Establishments. Its aim is to support high quality




clinical and scientific evaluation of Covid-19
Convalescent Plasma (CCP), using among other things
the dedicated database created by the European Commission.
The main goal of the project is to help EU countries
in both assessing the efficacy of a new therapeutic
solution to deal with the current Coronavirus crisis and
developing new strategies to face potential future pandemics.

Learn more about Support-e >
Learn more about the CCP Database >

Objectives

I

Support High Quality
CCP donation

II

Support High Quality CCP Evaluation in clinical trials and monitored access use programmes

III

Deliver Recommendations for the collection and use of CCP in EU member states to treat Covid-19

IV

Deliver Recommendations for future outbreaks

V

Ensure EU wide adoptions of recommendations and project legacy

News

“Convalescent Plasma for Covid-19 – Making Sense of the Inconsistencies”, an editorial of Lise Estcourt (WP5) on the NEJM

“We owe it to blood donors, blood centres, taxpayers, and our patients not to deploy unproven therapies until a consistent efficacy signal is observed”, wrote Dr. Estcourt
Learn more >

The layman’s version of the Interim Report is now online

The layman's version of the Support-e Project Interim Report is now available. You can download it by clicking on this link.
Learn more >

SUPPORT-E Consortium: “Covid-19 convalescent plasma should be further investigated”

On December 7th, the WHO updated its living guideline on COVID-19 therapeutics, including convalescent plasma (CCP). This led to their recommendation against the use of CCP for COVID-19 patients. As the SUPPORT-E Consortium we wish to respond to these recommendations.
Learn more >